Plain-English translation of NCT06681610 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial pulse stimulation (TPS), a device that uses gentle sound waves to stimulate the motor part of your brain — the area that controls movement. Researchers want to see if this non-invasive treatment can help improve or maintain muscle function in people with ALS. Half of participants will receive the real treatment, and half will receive a sham (fake) treatment, so researchers can fairly compare whether the real device makes a difference.
ALS progressively weakens the muscles that control movement, and there are limited treatment options available. This trial is exploring whether stimulating the brain's motor cortex with sound waves might help protect nerve cells or improve muscle control, offering a new hope for slowing disease progression.
You likely qualify if…
You likely don't qualify if…
You will receive six treatment sessions over two weeks, with each session lasting about 20 minutes. During each session, the device will be placed on your head and deliver sound wave pulses to the motor area of your brain. The study has two stages: in the first stage (8 weeks), researchers measure changes in your brain's electrical activity; in the second stage (6 months), they track changes in your motor function using a standard ALS assessment scale. You won't know whether you're receiving the real treatment or the sham treatment until the study ends.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Spain